ENST00000363046.2:n.-11A>C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The ENST00000363046.2(RMRP):​n.-11A>C variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000564 in 682,932 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00031 ( 0 hom. )

Consequence

RMRP
ENST00000363046.2 upstream_gene

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: -4.18

Publications

0 publications found
Variant links:
Genes affected
RMRP (HGNC:10031): (RNA component of mitochondrial RNA processing endoribonuclease) This gene encodes the RNA component of mitochondrial RNA processing endoribonuclease, which cleaves mitochondrial RNA at a priming site of mitochondrial DNA replication. This RNA also interacts with the telomerase reverse transcriptase catalytic subunit to form a distinct ribonucleoprotein complex that has RNA-dependent RNA polymerase activity and produces double-stranded RNAs that can be processed into small interfering RNA. Mutations in this gene are associated with cartilage-hair hypoplasia.[provided by RefSeq, Mar 2010]
RMRP Gene-Disease associations (from GenCC):
  • cartilage-hair hypoplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 9-35658030-T-G is Benign according to our data. Variant chr9-35658030-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 550921.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RMRPNR_003051.4 linkn.-11A>C upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RMRPENST00000363046.2 linkn.-11A>C upstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.00145
AC:
220
AN:
152218
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00466
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000719
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000578
AC:
72
AN:
124488
AF XY:
0.000528
show subpopulations
Gnomad AFR exome
AF:
0.00497
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000971
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000149
Gnomad OTH exome
AF:
0.000787
GnomAD4 exome
AF:
0.000305
AC:
162
AN:
530596
Hom.:
0
Cov.:
0
AF XY:
0.000270
AC XY:
77
AN XY:
284938
show subpopulations
African (AFR)
AF:
0.00366
AC:
56
AN:
15294
American (AMR)
AF:
0.000990
AC:
33
AN:
33346
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19446
East Asian (EAS)
AF:
0.0000316
AC:
1
AN:
31668
South Asian (SAS)
AF:
0.000129
AC:
8
AN:
61784
European-Finnish (FIN)
AF:
0.0000303
AC:
1
AN:
32968
Middle Eastern (MID)
AF:
0.000422
AC:
1
AN:
2370
European-Non Finnish (NFE)
AF:
0.0000986
AC:
30
AN:
304172
Other (OTH)
AF:
0.00108
AC:
32
AN:
29548
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00146
AC:
223
AN:
152336
Hom.:
1
Cov.:
34
AF XY:
0.00140
AC XY:
104
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00474
AC:
197
AN:
41558
American (AMR)
AF:
0.000718
AC:
11
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68030
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000171
Hom.:
0
Bravo
AF:
0.00176
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 13, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The RMRP variant, n.-12A>C is located in the promoter region and is also referred to as n.-13A>C. Duplications in this region have been classified as pathogenic, although single nucleotide changes have not commonly been classified in this region to be pathogenic. The variant allele was found at a frequency of 0.00067 in 150636 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in RMRP causing Cartilage-Hair Hypoplasia (0.00067 vs 0.0072), allowing no conclusion about variant significance. n.-12A>C has been reported in the literature in an individual affected with Cartilage-Hair Hypoplasia, which authors indicate the cause for disease was g.97G>A and g.27G>C. Therefore, this variant was in cis with g.27G>C and assumed to be nonpathogenic by the authors (Cherkaoui Jaouad_2015). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as likely benign. Based on the evidence outlined above, the variant was classified as VUS - possibly benign. -

not provided Uncertain:1
Nov 07, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Metaphyseal chondrodysplasia, McKusick type Benign:1
Mar 22, 2017
Counsyl
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Anauxetic dysplasia Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RMRP-related disorder Benign:1
Feb 28, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.0090
DANN
Benign
0.44
PhyloP100
-4.2
PromoterAI
0.17
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372044910; hg19: chr9-35658027; API